Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT 3 receptor antagonists and dexamethasone.

Int J Clin OncolJul 21, 2026 (epub)
Clinical ResearchOncology (Medical)Open access

Takeshi Aoyama, Hirotoshi Iihara, Masakazu Abe et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluated the comparative effectiveness of 5-HT3 receptor antagonists versus dexamethasone for preventing chemotherapy-induced nausea and vomiting in adult patients receiving low-emetogenic chemotherapy. The review found no direct comparative evidence from randomized controlled trials or observational studies, highlighting a significant gap in the literature.

Key findings

  • No direct comparative evidence was found between 5-HT3 receptor antagonists and dexamethasone for low-emetogenic chemotherapy.
  • The review screened 430 articles, ultimately including no studies that met the inclusion criteria.
  • Future research should focus on prospective comparative trials and real-world data analyses.

Why it matters

Understanding the effectiveness of antiemetic therapies is crucial for improving patient quality of life during chemotherapy. This review underscores the need for robust evidence to guide clinical practice in managing chemotherapy-induced nausea and vomiting.

Source

Published in Int J Clin Oncol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.